| Trial ID: | L1359 |
| Source ID: | NCT00560976
|
| Associated Drug: |
Iron Saccharate (Venofer)
|
| Title: |
Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Renal Failure Chronic Requiring Hemodialysis
|
| Interventions: |
DRUG: Iron Saccharate (Venofer)
|
| Outcome Measures: |
Primary: CRP (C-Reactive Protein) and AOPP (Advanced Oxidative Protein Products) Levels, To assess the effects of 100 mg IV iron in the first hour of the first weekly HD on the relation of pre IV iron serum NGAL levels with oxidative stress and inflammation related parameters. |
|
| Sponsor/Collaborators: |
Sponsor: Soroka University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-12
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2013-04-18
|
| Locations: |
Department of Nephrology, Soroka University Medical center, Beer-Sheva, 84101, Israel|Bnai-zion Medical Center,Nephrology,, Haifa, Israel|Department of Nephrology, Wolfson Medical Center, Holon, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00560976
|
